A pioneering pharmaceutical company dedicated to developing cutting-edge small molecules targeting Sortilin, with a focus on groundbreaking solutions for cancer and beyond. Sortina pharma has a commitment to revolutionizing cancer therapeutics, addressing limitations and projecting a new era in treatment strategies to promote cure of cancer
GUV Contact: Sara Malcus